New European Patent Granted

 

09 January 2007

ARTES announces the grant of the European patent on increasing recombinant protein secretion in yeast by co-expression of Calnexin, a protein responsible in intracellular quality control and sorting.

In extensive studies, ARTES could show that overexpression of Calnexin results in significant increase of protein secretion, independent of the nature of product or the size of fermentation. This technology further boosts the already high level of protein secretion in Hansenula but also in other yeast species.

The Calnexin patent is co-owned by ARTES Biotechnology GmbH and Rhein Biotech GmbH.


Post to:
Delicious  
Digg  
reddit  
Facebook  
StumbleUpon  


Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development